Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
News Focus
Canada Jetlines Announces $13.5 Million Equity Financing (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Plus Therapeutics Inc
PSTV
Healthcare
Biotechnology
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company develops a targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers. Its lead radiotherapeutic candidate, Rhenium (186Re) obisbemeda is designed specifically to CNS cancers including recurrent...
glioblastoma (GBM), leptomeningeal metastases (LM), and pediatric brain cancers (PBC) by direct localized delivery utilizing approved standard-of-care tissue access such as with convection-enhanced delivery (CED) and intraventricular brain (Ommaya reservoir) catheters. The Company’s Rhenium (186Re) obisbemeda, a novel injectable radiotherapy designed to deliver targeted, high dose radiation directly into GBM tumors. The Company’s portfolio also includes 188RNL-BAM, a radioembolization therapy for liver cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PSTV)
New Post
View:
Posts & Comments
Threaded Posts
(17)
•••
whytestocks
X
Post by
whytestocks
on Jul 13, 2023 8:15pm
Plus Therapeutics to Present at the 2nd Annual Targeted Radi
Just In: $PSTV Plus Therapeutics to Present at the 2nd Annual Targeted Radiopharmaceuticals SummitAUSTIN, Texas, July 13, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the &
...more
(17)
•••
whytestocks
X
Post by
whytestocks
on Jun 14, 2023 9:00pm
Plus Therapeutics to Participate in the 2023 Healthcare Virt
BREAKING NEWS: $PSTV Plus Therapeutics to Participate in the 2023 Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-VestAUSTIN, Texas, June 14, 2023 (GLOBE NEWSWIRE) -- Plus
...more
Canada Nickel Announces Successful Completion of Carbon Storage Pilot Plant
posted Oct 02, 2023 9:00am by
Canada Nickel Company Inc
-
|
The Company processed more than 7 tonnes of tailings and confirmed the engineering design parameters for IPT Carbonation for incorporation in the Integrated Feasibility Study ("IFS") expected to be released on October 12, 2023. The pilot plant also was utilized to successfully apply the IPT Carbonation process to material from a third party's project, demonstrating the potential to commercialize the process for other projects including the Company's regional nickel properties in the Timmins Nickel District. ...read more
(84)
•••
Chester55
X
Post by
Chester55
on Aug 21, 2021 9:46am
I guess there is t anyone talking about this stock
Crickets. Well I like this stock!! Join me!!
(82)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 11, 2021 12:34pm
In some here....
Cheers !
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Dec 16, 2019 8:38pm
still holding this stock
used dollar cost averaging for it after getting caught by an upswing followed by a cheap stock financing,so glta shareholders but it could take time for an upswing here.
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Sep 25, 2019 2:51pm
it's a buy today for me
my last batch at these low prices,so glta shareholders.
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Sep 24, 2019 10:30am
still holding this stock
adding more shares this morning after the cheap financing yesterday collapsed the stock price, using dollar cost averaging on this one,so glta shareholders.
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Sep 23, 2019 2:21pm
the bottom is past for
people playing with it all day but its value is $16 per share,so glta shareholders.
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Sep 23, 2019 2:18pm
still holding this stock
this stock is way oversold,so glta shareholders.
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Sep 23, 2019 2:10pm
it's a buy today for me using DCA
by dollar cost averaging,and by loading up big time with this one,my target price for it is $16 per share,and my costs are $5.00 per share,and still waiting for more beaten down cheap shares.
(668)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Sep 23, 2019 10:53am
it's a buy today for me
at $11.15 cents per share,so glta.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
A small-cap fintech company is gearing up for global domination
Harness the Power: Elevate Your Understanding of Battery Metals & EVs - Free Insights Report Av alible
Canada Nickel Announces Successful Completion of Carbon Storage Pilot Plant
Canada Jetlines Announces $13.5 Million Equity Financing
New Copper Targets and Plans to Drill at Marshall Lake, Ontario
This Company is bringing Critical Materials Supply back to Europe